Stability study of topotecan in ophthalmic prefilled syringes for intravitreal delivery
Bello W, Hosotte C, Stampfli C, Pierrot A, Munier F L, Berger-Gryllaki M, Pezzatti J, Carrez L, Sadeghipour F. (farshid.sadeghipour@chuv.ch)
EJHP - 2025 - 33:67-72

Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns.
Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F. (david.palmero@chuv.ch)
EJHP - 2018 - ; 25, e2

Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU.
Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F. ()
EJHP - 2015 - ;22:123-124.

Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie.
Chavan E. ()
Master en pharmacie - University of Geneva - 2014 -

In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs
Humbert-Delaloye V, Berger M, Voirol P, Pannatier A. (valia.humbert-delaloye@ chuv.ch)
EJHP - 2012 - ; 19: 57-64.

Compatibilités physico-chimique entre catécholamines, amiodarone, et/ou nitroprussiate de sodium intraveineux.
Humbert-Delaloye V, Berger M, Pannatier A. ()
16èmes JFSPH, Sion, 18-19 novembre 2010 - 2010 -

The development of a stable oral solution of captopril for paediatric patients.
Berger-Gryllaki M, Podilsky G, Widmer N, Gloor S, Testa B, Pannatier A. ()
EJHP Science - 2007 - ; 13-67-72.